Almost 300 global healthcare professionals involved in treating patients with opioid addictions convened recently at the 15th annual Improving Outcomes in the Treatment of Opioid Dependence (IOTOD) conference in Berlin, Germany, for 2 days of innovative and interactive education focused on improving patient management.
This CME-accredited conference has been run by PCM Scientific for the past 14 years, and has become a flagship meeting in the field of addictions therapy, resulting year-on-year in measurable changes in physicians’ practice, thus benefiting the lives of many patients worldwide. The meeting was chaired by John Marsden, Professor of Addiction Psychology, at King’s College London, UK.
Over the 2 days, delegates participated in multiple sessions including plenary sessions, training masterclasses, a diagnostic patient mystery, case study clinics and a Hepatitis C workshop. Once again, the conference encouraged delegates to reflect on and submit their own personal commitments to change in their daily practice; they will then be followed up at 3- and 12-month timepoints to assess whether these commitments have led to sustained changes in clinical practice.
Delegate feedback again highlighted the importance of IOTOD to clinicians working in the field of addictions:
- “Fantastic conference. Very interesting, interactive and very educative. I found the conference relevant to my practice and will definitely influence change in my practice.”
- “Thank you very much for the passionate and inspiring lectures.”
- “Hepatitis C session was wonderful, a great motivator to test and treat!”
- “The interactive approach is brilliant.”
The conference also allowed PCM Scientific to announce the date of next year’s IOTOD meeting, which will be held in Madrid, Spain, in the week beginning May 14th 2018.
Registration will open soon – visit our website to find out more.
Improving Outcomes in the Treatment of Opioid Dependence (IOTOD) 2017 is supported by an educational grant from Indivior. ‘Workshop – Complexities and commonalities in hepatitis C care’ is supported by an educational grant from Merck and Company. The educational programme is run at arm’s length from the financial supporters and all content is created by the faculty. No funder has had input into the content of the materials or presentations used in the educational programme. PCM Scientific is the medical education company acting as Scientific Secretariat and Conference Organiser.